1. Nonpathogenic E. coli engineered to surface display cytokines as a new platform for immunotherapy. Yang S, Sheffer M, Kaplan IE, Wang A, Tarannum M, Dinh K, Abdulhamid Y, Shapiro R, Soiffer R, Ritz J, Koreth J, Wei Y, Chen P, Zhang K, Marquez-Pellegrin V, Bonanno S, Joshi N, Guan M, Yang M, Li D, Bellini C, Chen J, Wu CJ, Barbie D, Li J, Romee R. Nature Biotechnol, 2024, Oct 4 (online ahead of print). PMID: 39367093
2. Memory-like NK CAR cells targeting the membrane-proximal domain of mesothelin demonstrate promising activity against ovarian cancer cell lines, patient-derived xenograft explants, and in pre-clinical xenograft mice. Tarannum M, Dinh K, Vergara J, Birch G, Adulhamid YZ, Kaplan IE, Ay O, Maia A, Beaver O, Sheffer M, Shapiro R, Ali AK, Dong H, Ham JD, Bobilev E, Ganapathy S, Chayawatto C, Koreth J, Cloud PP, Gokhale P, Barbie DA, Matulonis UA, Soiffer RJ, Ritz J, Porter RL, Chen J, Romee R. Science Advances,2024, Jul 12;10(28):eadn0881. PMID: 38996027. PMC11244547. https://doi.org/10.1126/sciadv.adn0881. Epub 2024 Jul 12.
3. Shapiro RM, Birch GC, Hu G, Vergara Cadavid J, Nikiforow S, Baginska J, Ali AK, Tarannum M, Sheffer M, Abdulhamid YZ, Rambaldi B, Arihara Y, Reynolds C, Halpern MS, Rodig SJ, Cullen N, Wolff JO, Pfaff KL, Lane AA, Lindsley RC, Cutler CS, Antin JH, Ho VT, Koreth J, Gooptu M, Kim HT, Malmberg KJ, Wu CJ, Chen J, Soiffer RJ, Ritz J, Romee R.J Clin Invest, 2022, Jun 1;132(11). PMID: 35349491.
4. Memory-like NK cells armed with a neoepitope-specific CAR exhibit potent activity against NPM1 mutated acute myeloid leukemia. Dong H, Ham JD, Xie G, Vergara J, Ali A, Tarannum M, Donner H, Baginska J, Abdulhamid Y, Dinh K, Soiffer RJ, Ritz J, Glimcher LH, Chen J, Romee R. Proct Natl Acad Sci USA (PNAS), 2022, Jun 21;119(25): e2122379119. PMID: 35696582, PMCID: PMC9231490. Full list of publications: